Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – A novel VEGFR inhibitor, tivozanib, improves progression-free survival significantly in patients with metastatic renal cell carcinoma but does not improve overall survival, according…
David Sayen, Regional Manager, Centers for Medicare and Medicaid Services, discusses the shift in health insurance programs from fee-for-service to an “accountable care” model, in which incentives are…
NEW YORK (Reuters Health) – In a large randomized study of hemodialysis patients with new arteriovenous grafts, daily fish oil supplementation didn’t improve long-term graft patency. However, those…
NEW YORK (Reuters Health) – In populations with low prevalence of latent tuberculosis infection, the majority of positive results on the tuberculin skin test (TST) and the newer…
NEW YORK (Reuters Health) – A 4-year placebo-controlled trial of alpha-lipoic acid to treat diabetes-related polyneuropathy produced no improvement in the study’s composite endpoint, but there were clinically…
NEW YORK (Reuters Health) – When unfavorable anatomy of the cardiac veins impedes transvenous placement of left ventricular leads for cardiac resynchronization therapy (CRT), implantation via a minithoracotomy…
Join us for our Abstract Highlights – ADA Scientific Sessions 2011 – Look AHEAD Trial Results. Participants in the 2011 ADA Scientific Sessions were briefed on the results…
NEW YORK (Reuters Health) – Women who are positive for human papilloma virus (HPV) and have low-grade cervical cytological abnormalities but normal colposcopic findings are at low risk…
